The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.036
Bid: 0.032
Ask: 0.04
Change: -0.0015 (-4.00%)
Spread: 0.008 (25.00%)
Open: 0.0375
High: 0.0375
Low: 0.036
Prev. Close: 0.0375
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Funding and Funding Restructuring

11 Oct 2022 07:00

RNS Number : 4622C
Dukemount Capital PLC
11 October 2022
 

Dukemount Capital Plc11th October 2022

 

Dukemount Capital Plc

 ("Dukemount" or the "Company")

Further Funding and Funding Restructuring

 

Dukemount announces that, further to the disposal of the peakers as announced on 5 October 2022, the lenders (as detailed in the announcement of 15 September 2021) (the "Investors") have agreed to advance (the "Further Advance") the net proceeds of £50,000 in aggregate in addition to restructuring their existing funding arrangement. The maturity date for the existing debt plus the Further Advance is to be 24 months from the date of the Advance (being 10 October 2024).

 

The proceeds of the Further Advance have been used to settle accrued liabilities of the Company.

 

The board has taken steps to ensure that the financial position and prospects of the Company are maintained to facilitate a future reverse transaction. To that end, the board confirm the following has been undertaken:

- Geoffrey Dart and Paul Gazzard have released the Company from all accrued but unpaid emoluments;

- Chesterfield Capital Limited have confirmed that the outstanding balance of £500,000 due to Chesterfield Capital Limited will be converted at the previously announced subscription price of 0.65p. Such subscription to settle all balances due from the Company and to be settled by the issuance of shares at the earlier of (a) the approval of a prospectus, (b) the direction of the board of the Company and (c) 11 April 2023.

 

Terms of the Restructuring and the Further Advance

 

The key terms of the restructuring and the Further Advance being:

- 24 month term for the balances

- The debt is convertible at the nominal value of 0.1p of the ordinary shares of the Company

- The further advance is subject to the previously announced 5% implementation fee

- The Company has agreed to settle a 9.5% extension fee of £74,575 to the Noteholders in the form of ordinary shares at nominal value

 

Paul Gazzard CEO, comments "we are happy to work with the Investors to ensure that the Company is financed for the next steps as we work towards identifying a suitable reverse takeover target which will be for the benefit of all the investors who have committed to the work we have sought to do with the Company. We hugely appreciate the further support and capital injection from the Investors which, alongside our personal releases, we believe the Company to be well positioned for the immediate steps of securing a transaction. We expect to announce further updates on this process in the coming weeks"

 

 

Market Abuse Regulation (MAR) disclosure

 

Certain statements in this announcement contain inside information for the purpose of Article 7 of EU Regulation 596/2014.

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc

Geoffrey Dart / Paul Gazzard

Media Enquries

 

Miriad Media, Zak Mir

Tel: +44 (0)7867 527 659

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REPGPGCCUUPPUAG
Date   Source Headline
4th Aug 202011:25 amRNSHolding(s) in Company
1st Jul 20207:48 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSAppointment of Chief Executive Officer
26th Jun 20209:45 amRNSHolding(s) in Company
23rd Jun 202010:46 amRNSHolding(s) in Company
15th Jun 20201:31 pmRNSHolding(s) in Company
10th Jun 20202:28 pmRNSExercise of Warrants - Issue of Equity
18th May 20203:26 pmRNSWavertree COVID-19 Update.
7th May 202010:02 amRNSHolding(s) in Company
5th May 20201:24 pmRNSAdmission To Trading For Placing Shares
1st May 202011:21 amRNSAdmission To Trading For Bonus Shares
30th Apr 20204:59 pmRNSHolding(s) in Company
22nd Apr 20207:00 amRNSIssue of Equity
9th Apr 20207:00 amRNSWest Derby COVID-19 Update
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 202011:01 amRNSWavertree COVID-19 Update
26th Mar 20207:00 amRNSWavetree Project at Final Fit Out
23rd Mar 20204:17 pmRNSResult of AGM
19th Mar 20208:30 amRNSStatement re AGM
26th Feb 20202:00 pmRNSNotice of AGM
29th Jan 20204:41 pmRNSSecond Price Monitoring Extn
29th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20202:45 pmRNSHalf-year Report
30th Aug 20193:08 pmRNSFinal Results
31st Jul 20194:41 pmRNSSecond Price Monitoring Extn
31st Jul 20194:35 pmRNSPrice Monitoring Extension
25th Jul 201910:10 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSWest Derby Development Update
17th Jun 20197:00 amRNSNew Website Released
10th Jun 20192:44 pmRNSHolding(s) in Company
7th Jun 201911:07 amRNSHolding(s) in Company
5th Jun 20191:44 pmRNSHolding(s) in Company
3rd Jun 20194:44 pmRNSHolding(s) in Company
30th May 20193:40 pmRNSHolding(s) in Company
29th May 201910:20 amRNSHolding(s) in Company
20th May 20193:26 pmRNSHolding(s) in Company
20th May 201911:14 amRNSHolding(s) in Company
14th May 201910:31 amRNSHolding(s) in Company
26th Apr 20191:03 pmRNSHolding(s) in Company
2nd Apr 20197:00 amRNSCompletion of West Derby Building Contract
25th Mar 20197:00 amRNSCompletion of Wavertree Building Contract
12th Feb 201910:19 amRNSHolding(s) in Company
11th Feb 20194:00 pmRNSResultant Holding Following Issue of Shares
4th Feb 20197:00 amRNSBoard Change
4th Feb 20197:00 amRNSResult of AGM
31st Jan 20197:20 amRNSIssue of Shares
31st Jan 20197:10 amRNSInterim Results
31st Jan 20197:00 amRNSWavertree Development Agreement
8th Jan 20197:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.